Evonik Industries AG

EVK

Equity

ISIN DE000EVNK013 / Valor 18699457

Xetra (2026-10-02)

EUR 20.64+0.10%

Evonik Industries AG
UMushroom community rating:

4.67 3 votes No rating yet

NegativeNeutralPositive

About company

Evonik Industries AG is a Germany-based specialty chemicals company that develops, manufactures and sells chemical intermediates, additives and ingredient solutions for a broad set of industrial and consumer markets, including animal nutrition and feed amino acids, personal-care and pharmaceutical ingredients, specialty polymers and additives for plastics and coatings, catalysts and silica-based products. The company supplies formulators and industrial customers with tailored chemical technologies and operates a global network of production and research facilities while distributing through regional business units and direct sales; it is publicly listed on the Frankfurt stock exchange.

Summarized from source with an LLMView SourceSector: Industrials

Revenue and growth

Group sales: €3,893m in Q2 2026 (+11% vs Q2 2025). Volume growth was +7% and price contribution was +7% in the quarter, indicating broad underlying demand recovery plus favorable pricing.

Profitability (adjusted)

Adjusted EBITDA rose to €630m in Q2 2026 (margin 16.2%), +24% vs Q2 2025. Adjusted EBIT increased to €370m (+48% vs Q2 2025) and adjusted net income reached €296m for the quarter, lifting adjusted EPS to €0.65 (Q2 2025: €0.34).

Reported earnings vs. adjustments

Reported EBIT was €163m in Q2 2026, below the adjusted figure due to special items: total adjustments in Q2 2026 were €‑207m (notably other special items of ≈€‑159m and restructuring charges ≈€‑48m). These special items caused the gap between adjusted and reported results.

Cash flow and balance sheet

Operating cash flow in Q2 2026 was €229m; capex was €180m and free cash flow came in at €49m for the quarter. Cash and cash equivalents were €390m at quarter end and net financial debt was €‑3,620m.

Segment performance

Advanced Technologies: sales €1,647m in Q2 2026 (+9% y/y). Custom Solutions: sales €1,422m (+4% y/y). Infrastructure & Other: sales €824m (notable increase vs prior-year quarter). Adjusted EBITDA margins improved across the group, supporting the stronger adjusted operating result.

ESG / other KPIs

Evonik continues to report sustainability metrics separately; the most recent published KPI shows the FY 2025 sales share of "Next Generation Solutions" at 48%. Other ESG indicators (GHG emissions, training rates, supplier assessments) are included in the full IR KPI set.

Summarized from source with an LLMView Source

Key figures

39.2%1Y

21.5%3Y

-23.3%5Y

Performance

26.7%1Y

25.0%3Y

26.2%5Y

Volatility